CA1138772A - Canine parvovirus vaccine - Google Patents

Canine parvovirus vaccine

Info

Publication number
CA1138772A
CA1138772A CA000342265A CA342265A CA1138772A CA 1138772 A CA1138772 A CA 1138772A CA 000342265 A CA000342265 A CA 000342265A CA 342265 A CA342265 A CA 342265A CA 1138772 A CA1138772 A CA 1138772A
Authority
CA
Canada
Prior art keywords
vaccine
canine
cell culture
canine parvovirus
cpv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000342265A
Other languages
English (en)
French (fr)
Inventor
Max J.G. Appel
Leland E. Carmichael
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Original Assignee
Cornell Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc filed Critical Cornell Research Foundation Inc
Application granted granted Critical
Publication of CA1138772A publication Critical patent/CA1138772A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA000342265A 1978-12-20 1979-12-19 Canine parvovirus vaccine Expired CA1138772A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US971,296 1978-12-20
US05/971,296 US4193991A (en) 1978-12-20 1978-12-20 Canine parvovirus vaccine

Publications (1)

Publication Number Publication Date
CA1138772A true CA1138772A (en) 1983-01-04

Family

ID=25518175

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000342265A Expired CA1138772A (en) 1978-12-20 1979-12-19 Canine parvovirus vaccine

Country Status (11)

Country Link
US (1) US4193991A (enExample)
EP (1) EP0020743A1 (enExample)
JP (1) JPS6330287B2 (enExample)
AU (1) AU532290B2 (enExample)
CA (1) CA1138772A (enExample)
DE (1) DE2953417C2 (enExample)
GB (1) GB2048071B (enExample)
NL (1) NL7920193A (enExample)
NZ (1) NZ192477A (enExample)
SE (1) SE423312B (enExample)
WO (1) WO1980001243A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303645A (en) * 1980-04-18 1981-12-01 Cornell Research Foundation, Inc. Modified living canine parvovirus vaccine
JPS58408B2 (ja) * 1980-09-04 1983-01-06 株式会社 微生物化学研究所 イヌパルボウイルス感染症不活化ワクチン
US4572834A (en) * 1984-04-10 1986-02-25 Clinical Reference Laboratory, Inc. Biologic and method of preparing same
GB8502399D0 (en) * 1985-01-31 1985-03-06 Akzo Nv Canine parvovirus vaccines
US4971793A (en) * 1988-05-09 1990-11-20 Boyce Thompson Institute For Plant Research, Inc. Subunit canine parvovirus vaccine
DE69023140T2 (de) * 1989-08-08 1996-03-21 Webster Arthur Pty Ltd Attenuiertes hundeparvovirus (cpv), cpv enthaltender impfstoff und verfahren zur verhütung von infektionen durch cpv bei hunden.
AU633349B2 (en) * 1989-08-08 1993-01-28 Fort Dodge Australia Pty Limited Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
US5814510A (en) * 1994-11-08 1998-09-29 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US5885585A (en) * 1994-11-08 1999-03-23 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US6168915B1 (en) * 1998-04-24 2001-01-02 Diagnostic Hybrids, Inc. Mixed cell diagnostic systems
US20060094105A1 (en) 1998-04-24 2006-05-04 University Hospitals Of Cleveland Mixed cell diagnostic systems for detection of respiratory, herpes and enteric viruses
US6946291B2 (en) * 1998-04-24 2005-09-20 University Hospitals Of Cleveland Mixed cell diagnostic systems
CA2510189A1 (en) * 2002-12-19 2004-07-08 Thomas Gore Trivalent vaccine with maternal antibody transfer via the milk
RU2242994C1 (ru) * 2003-08-05 2004-12-27 Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных Штамм № r-72 вниизж парвовируса собак для изготовления диагностических и вакцинных препаратов
PL2236155T3 (pl) 2004-09-09 2012-10-31 Novartis Ag Zmniejszenie potencjalnego zagrożenia jatrogennego związanego ze szczepionkami przeciwko grypie
US7435588B2 (en) * 2005-09-20 2008-10-14 Diagnostic Hybrids, Inc. Systems for detection and production of respiratory, herpes and enteric viruses
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
CN106048082A (zh) * 2007-06-14 2016-10-26 俄克拉荷马州大学评议会 包含犬细小病毒遗传性变体的疫苗
EP2391713A1 (en) 2009-01-30 2011-12-07 The Board Of Regents For Oklahoma State University Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs
EP2488634A4 (en) 2009-10-14 2013-04-03 Univ Oklahoma State ISOLATION OF A VIRUS RELATED TO DOG PARVOVIRUS 2 IN A WASHBASIN
CN104324272A (zh) * 2014-11-23 2015-02-04 烟台海研制药有限公司 治疗犬细小病毒病的中药组合物
AU2021223783A1 (en) 2020-02-21 2022-08-18 Intervet International B.V. Novel erythroparvovirus associated with respiratory distress in equine

Also Published As

Publication number Publication date
GB2048071A (en) 1980-12-10
JPS6330287B2 (enExample) 1988-06-17
DE2953417C2 (de) 1987-08-20
AU532290B2 (en) 1983-09-22
GB2048071B (en) 1983-09-21
NZ192477A (en) 1983-02-15
EP0020743A1 (en) 1981-01-07
SE423312B (sv) 1982-05-03
SE8005824L (sv) 1980-08-19
DE2953417T1 (enExample) 1981-01-29
WO1980001243A1 (en) 1980-06-26
US4193991A (en) 1980-03-18
AU5405679A (en) 1980-06-26
NL7920193A (nl) 1980-10-31
JPS55501177A (enExample) 1980-12-25

Similar Documents

Publication Publication Date Title
CA1138772A (en) Canine parvovirus vaccine
Minamoto et al. Isolation and characterization of rotavirus from feral pigeon in mammalian cell cultures
US5316764A (en) Canine Parvovirus vaccines
CN106267195B (zh) 一种猪病毒性腹泻三联抗原抗体复合物及其制备方法
Csiza et al. Pathogenesis of feline panleukopenia virus in susceptible newborn kittens I. Clinical signs, hematology, serology, and virology
EP0023922B1 (en) Heterotypic canine parvovirus vaccine
Ojeh et al. Evidence for serotypic variation among bovine rotaviruses
Reynolds et al. Virus isolation and serum antibody responses after infection of cats with transmissible gastroenteritis virus
US5916570A (en) Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
JPS6330288B2 (enExample)
US5118502A (en) Naturally attenuated newcastle disease vaccine and method of using the same
Straver et al. Isolation of malignant catarrhal fever virus from a European bison (Bos bonasus) in a zoological garden
CA2015828C (en) Canine corona virus vaccine
Morris et al. Recovery of a new syncytium virus from a cottontail rabbit
Ferris et al. An enzyme-linked immunosorbent assay for the detection of marine caliciviruses
Pensaert et al. A Porcine Enterovirus causing Fetal Death and Mummification: I. Characteristics and Identification
Muhammad et al. In process quality control factors affecting potency of foot and mouth disease virus vaccine
Hirai et al. Characterization of a new coronavirus-like agent isolated from parrots
NZ204437A (en) Vaccine preparation:inactivation of virus by nonionic detergent and cis-platinous halide complex
RU2127603C1 (ru) Инактивированная вакцина против инфекционной бурсальной болезни птиц
Zhang Studies on isolation, serum-free cultivation and manufacture of mink enteritis virus optimized for vaccine preparation
Tomori et al. Differentiation between two African arenaviruses(Lassa and Mozambique) by plaque assay.
Mattson et al. Isolation, identification, and characterization of six bovine picornavirus isolates
Aijian DEVEWPMENT OF AV ACCINE PROTECTIVE AGAINST VIRAL HEMORRHAGIC DISEASE

Legal Events

Date Code Title Description
MKEX Expiry